Sec Form 13G Filing - Kumar Neil filing for BRIDGEBIO PHARMA INC (BBIO) - 2021-02-16

  NAME OF REPORTING PERSONS

  S.S. OR I.R.S IDENTIFICATION NOS. OF ABOVE PERSONS

  NEIL KUMAR

  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

  (a)  ☐        (b)  ☒

  SEC USE ONLY

  CITIZENSHIP OR PLACE OF ORGANIZATION

  U.S.

NUMBER OF

SHARES

 BENEFICIALLY 

OWNED BY

EACH

REPORTING

PERSON

WITH

  SOLE VOTING POWER

  5,522,189

  SHARED VOTING POWER

  2,808,408

  SOLE DISPOSITIVE POWER

  5,522,189

  SHARED DISPOSITIVE POWER

  2,808,408

  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

  8,330,597 (1)

  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

  ☐

  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

  6.74%

  TYPE OF REPORTING PERSON*

  IN

Consists of (i) 4,692,435 shares of Common Stock held directly by Dr. Kumar, (ii) 824,625 shares of Common Stock issuable to Dr. Kumar upon the exercise of stock options exercisable within 60 days of December 31, 2020, (iii) 5,129 shares of Common Stock issuable to Dr. Kumar upon the vesting and settlement of restricted stock units within 60 days of December 31, 2020, (iv) 1,612,722 shares of Common Stock held by the Kumar Haldea Revocable Trust, of which Dr. Kumar is a co-trustee and (v) 1,195,686 shares of Common Stock held by the Kumar Haldea Family Irrevocable Trust, of which Dr. Kumar is a co-trustee.

Percentage ownership is based on (i) 122,849,389 shares of Common Stock outstanding as of December 31, 2020, (ii) 824,625 shares of Common Stock underlying stock options held by Dr. Kumar that are exercisable within 60 days of December 31, 2020 and are deemed outstanding pursuant to SEC Rule 13-3(d)(1)(i) and (iii) 5,129 shares of Common Stock underlying restricted stock units held by Dr. Kumar that are subject to vesting and settlement within 60 days of December 31, 2020 and are deemed outstanding pursuant to SEC Rule 13-3(d)(1)(i).

Name of Issuer:

Address of Issuer’s Principal Executive Offices:

Name of Person Filing:

Address of Principal Business Office or, if None, Residence:

Citizenship:

Title of Class of Securities:

CUSIP Number:

If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

Ownership.

Amount Beneficially Owned: 8,330,597 shares of Common Stock, which represents (i) 4,692,435 shares held of record by Neil Kumar, (ii) 824,625 shares of Common Stock issuable to Dr. Kumar upon the exercise of stock options exercisable within 60 days of December 31, 2020, (iii) 5,129 shares of Common Stock issuable to Dr. Kumar upon the vesting and settlement of restricted stock units within 60 days of December 31, 2020, (iv) 1,195,686 shares held of record by the Kumar Haldea Family Irrevocable Trust and (v) 1,612,722 shares held of record by the Kumar Haldea Revocable Trust.

Percent of Class: 6.74%

Number of Shares as to which the person has:

Sole power to vote or to direct the vote: 5,522,189

Shared power to vote or to direct the vote: 2,808,408

Sole power to dispose or to direct the disposition of: 5,522,189

Shared power to dispose or to direct the disposition of: 2,808,408

Ownership of Five Percent or Less of a Class.

Ownership of More than Five Percent on behalf of Another Person.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.

Identification and Classification of Members of the Group.

Notice of Dissolution of Group.

Certification.